Forgot Password.
By Logging in, you are agreeing to the MedSearch Global Terms of Use and Privacy Policy.
Not a member? Sign Up
By Signing up, you are agreeing to the MedSearch Global Terms of Use and Privacy Policy.
Have an account? Log in
Back to Login? Log in
By registering in, you are agreeing to the MedSearch Global terms and condition and Privacy Policy.
Thinking of joining a study?
Register your interest
3926 results
Interventional
Not Applicable
200
OPTI-FREE EXPRESS MPDS and Alcon contact lens case
OPTI-FREE PureMoist MPDS and Alcon contact lens case
OPTI-FREE REPLENISH MPDS and Alcon contact lens case
Habitual contact lenses
Alcon Research
Source: clinicaltrials.gov
40
Interview
Medical Device Usage and Evaluation
Administration questionnaire
Virtual Technology Intervention
City of Hope Medical Center
Observational
223
Serum Raman spectroscopy intelligent diagnostic system
Fuzhou General Hospital
5
Myoelectric Implantable Recording Array (MIRA)
Boninger, Michael, MD
Phase2
20
Ceftriaxone treatment
Placebo
Hackensack Meridian Health
432
Learning Through Play plus Culturally adapted Cognitive Behaviour Therapy (LTP+CaCBT)
Treatment as Usual (TAU)
Nottingham Trent University
210
Use of NIV during FOB as a respiratory support method
Use of HFNC during FOB as a respiratory support method
Medical University of Silesia
316
Viscoelastic Tests (ROTEM)
Lyon Civilian Hospices
Phase4
160
Clarithromycin (mutations in the 23S rRNA gene, A2134G, A2142G and A2142C mutations) and levofloxacin resistance (mutations in the gyrA gene) PCR test
Empirically H. pylori eradication treatment with bismuth quadruple therapy (Pylera®)
PPI, amoxicillin 1 g and clarithromycin 500 mg, twice daily, for 10 days
PPI, amoxicillin 1g and levofloxacin 250 mg, twice daily, for 10 days
Bismuth quadruple therapy (Pylera®) for 10 days
Manuel Coelho da Rocha
61
accelerated cardiac cine-MRI sequence
University hospital center, Amiens